For SLE patients, the expression of LepR was generally comparable in patients with active disease and those in remission (Figure S3), assigning LepR deficiency in CD4 T cells as an inflammation-induced phenomenon unlikely. Here, LEPR is linked to systemic lupus erythematosus.